AMAR PATEL, MD
Ophthalmology Physician · TYLER, TX
Individual Active NPI 1871882449
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,852 | 49,467 | $23,206,826 | $4,410,739 | $3,455,273 |
| 2023 | 1,740 | 29,472 | $23,958,420 | $4,888,584 | $3,828,328 |
| 2022 | 1,448 | 19,706 | $19,334,284 | $4,318,496 | $3,404,406 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 25,140 | $34 | $27 |
| J2778 | Injection, ranibizumab, 0.1 mg | 9,728 | $159 | $123 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 4,530 | $147 | $116 |
| 67028 | Injection of drug into eye | 3,004 | $113 | $91 |
| 92134 | Imaging of retina | 2,931 | $39 | $30 |
| 92014 | Established patient complete exam of visual system | 2,298 | $124 | $94 |
| 92004 | New patient complete exam of visual system | 407 | $146 | $112 |
| J0178 | Injection, aflibercept, 1 mg | 370 | $816 | $642 |
| 92250 | Photography of the retina | 282 | $36 | $28 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 248 | $157 | $122 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 133 | $192 | $153 |
| 67228 | Destruction of leaking blood vessels of retina using laser | 59 | $332 | $264 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | S5043 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | S5043 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1376546226
- NPI 1407172828
- NPI 1558820381
- NPI 1528127172
- NPI 1326041377
- NPI 1588398127
- NPI 1780655340
- NPI 1831160548
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.